Capital raised in the biotech sector in Israel 2018-2022
According IVC and aMoon, the Israel's biotech sector raised over one billion U.S. dollars in capital in 2022. This was a significant increase of nearly 42 percent compared to the previous year. During the period under review, there was a steady increase in the value of capital raised in the sector. The total capital raised during these years exceeded three billion U.S. dollars.